Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-04-11 to 2025-04-14
Current total value of award: $8773.58
Description: 4567888055!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML